POST DEPILATORY LOTION O/W 30/CLSVG 4961/00

Symrise Pte Ltd
Phase
Product
INCI Name
Supplier
Volume
A
Dracorin® CE (614035)
Glyceryl Stearate Citrate
1
1.00
Lanette O
Cetearyl Alcohol
2
1.00
Cutina GMS-V
Glyceryl Stearate
2
0.50
Tegosoft MM
Myristyl Myristate
3
1.00
Abil 350
Dimethicone
3
0.50
Dragoxat® 89 (109854)
Ethylhexyl Isononanoate
1
2.00
PCL-Liquid 100 (660089)
Cetearyl Ethylhexanoate
1
4.00
Isodragol® (660061)
Triisononanoin
1
2.00
Neutral Oil (162412)
Caprylic/Capric Triglyceride
1
2.00
Carbopol Ultrez 21
Acrylates/C10-30 Alkyl Acrylate Crosspolymer
4
0.15
Keltrol T
Xanthan Gum
5
0.20
B
Water
Water (Aqua)
77.80
Glycerin 99,5 P.
Glycerin
3.00
Propylene Glycol-1, 2 99 P GC
Propylene Glycol
2.00
Dragocid® Liquid (660079)
Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben, Isobutylparaben
1
0.80
SymCalmin® (143535)
Butylene Glycol, Pentylene Glycol, Hydroxyphenyl Propamidobenzoic Acid
1
1.00
Sodium Benzoate
Sodium Benzoate
0.10
C
Sodium Hydroxide 10% solution
Sodium Hydroxide
0.45
D
SymRelief® (170015)
Bisabolol, Zingiber Officinale (Ginger) Root Extract
1
0.20
E
Fragrance
Parfum
1
0.30

Preparation:

Procedure Mix Phase A and B separately, without Carbopol and Keltrol, and heat up to 80°C. Disperse Keltrol and Carbopol in Phase A. Now blend Phase B without stirring to Phase A and homogenise. While homogenising add Phase C. Allow to cool down while stirring. Add Phase D at approx. 45°C and Phase E at room temperature. Properties pH: 5.8 Viscosity: 0.001 1/s - eta= 2257 Pas 5 1/s - eta= 9 Pas Rheology-Instrument: Haake RS1, sensor: PP 60/Ti, gap= 1.500 mm, T= 20°C, Controlled Stress Suppliers 1 Symrise GmbH & Co. KG 2 Cognis Dtl. GmbH 3 Degussa-Goldschmidt AG 4 Noveon 5 CP-Kelco
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

IFSCC 2024

Recanto das Cataratas Thermas Resort, Iguazu Falls, Brazil
14th - 17th October 2024

SEPAWA

Estrel Congress Center, Berlin
16th - 18th October 2024